Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Angiotensin receptor blockers and risk of myocardial infarction: systematic review.

McDonald MA, Simpson SH, Ezekowitz JA, Gyenes G, Tsuyuki RT.

BMJ. 2005 Oct 15;331(7521):873. Epub 2005 Sep 23. Review.

PMID:
16183653
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.

Bangalore S, Kumar S, Wetterslev J, Messerli FH.

BMJ. 2011 Apr 26;342:d2234. doi: 10.1136/bmj.d2234. Review.

PMID:
21521728
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.

Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.

Ann Intern Med. 2009 Dec 15;151(12):861-71. doi: 10.7326/0003-4819-151-12-200912150-00162. Review.

PMID:
20008762
[PubMed - indexed for MEDLINE]
4.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.

PMID:
17984484
[PubMed - indexed for MEDLINE]
5.

[Angiotensin II receptor blockers--evidence along the cardiovascular continuum].

Zeller A, Battegay E.

Praxis (Bern 1994). 2005 Apr 13;94(15):581-94. Review. German.

PMID:
15884724
[PubMed - indexed for MEDLINE]
6.

Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.

Epstein BJ, Gums JG.

Ann Pharmacother. 2005 Mar;39(3):470-80. Epub 2005 Feb 8. Review.

PMID:
15701766
[PubMed - indexed for MEDLINE]
7.

Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.

Tokmakova M, Solomon SD.

Curr Opin Cardiol. 2006 Jul;21(4):268-72. Review.

PMID:
16755193
[PubMed - indexed for MEDLINE]
8.

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.

Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC.

BMJ. 2004 Oct 9;329(7470):828. Epub 2004 Sep 30. Review.

PMID:
15459003
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine.

Ball SG, White WB.

Am J Cardiol. 2003 May 22;91(10A):15G-21G. Review.

PMID:
12781904
[PubMed - indexed for MEDLINE]
10.

Angiotensin II receptor blockers and myocardial infarction: deeds and misdeeds.

Volpe M, Mancia G, Trimarco B.

J Hypertens. 2005 Dec;23(12):2113-8. Review.

PMID:
16269950
[PubMed - indexed for MEDLINE]
12.

Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.

Caldeira D, Alarc√£o J, Vaz-Carneiro A, Costa J.

BMJ. 2012 Jul 11;345:e4260. doi: 10.1136/bmj.e4260. Review.

PMID:
22786934
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.

Gales BJ, Bailey EK, Reed AN, Gales MA.

Ann Pharmacother. 2010 Feb;44(2):360-6. doi: 10.1345/aph.1M312. Epub 2010 Jan 19. Review.

PMID:
20086184
[PubMed - indexed for MEDLINE]
14.

AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.

Azadpour M, Lamas GA.

Expert Rev Cardiovasc Ther. 2004 Nov;2(6):891-902. Review.

PMID:
15500434
[PubMed - indexed for MEDLINE]
15.

Angiotensin II type 1 receptor blockade: high hopes sent back to reality?

Grothusen A, Divchev D, Luchtefeld M, Schieffer B.

Minerva Cardioangiol. 2009 Dec;57(6):773-85. Review.

PMID:
19942847
[PubMed - indexed for MEDLINE]
16.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
[PubMed - indexed for MEDLINE]
17.

A systematic review of angiotensin receptor blockers in preventing stroke.

Lu GC, Cheng JW, Zhu KM, Ma XJ, Shen FM, Su DF.

Stroke. 2009 Dec;40(12):3876-8. doi: 10.1161/STROKEAHA.109.559989. Epub 2009 Nov 5. Review.

PMID:
19892999
[PubMed - indexed for MEDLINE]
Free Article
18.

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.

PMID:
18035185
[PubMed - indexed for MEDLINE]
19.

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.

Maione A, Navaneethan SD, Graziano G, Mitchell R, Johnson D, Mann JF, Gao P, Craig JC, Tognoni G, Perkovic V, Nicolucci A, De Cosmo S, Sasso A, Lamacchia O, Cignarelli M, Manfreda VM, Gentile G, Strippoli GF.

Nephrol Dial Transplant. 2011 Sep;26(9):2827-47. doi: 10.1093/ndt/gfq792. Epub 2011 Mar 3. Review.

PMID:
21372254
[PubMed - indexed for MEDLINE]
Free Article
20.

Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers.

Pfeffer MA.

Am Heart J. 2000 Jan;139(1 Pt 2):S23-8. Review.

PMID:
10618584
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk